Skip to main content

ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system.

Publication ,  Journal Article
Ford, LP; Watson, J; Keene, JD; Wilusz, J
Published in: Genes Dev
January 15, 1999

We have developed an in vitro mRNA stability system using HeLa cell cytoplasmic S100 extracts and exogenous polyadenylated RNA substrates that reproduces regulated aspects of mRNA decay. The addition of cold poly(A) competitor RNA activated both a sequence-specific deadenylase activity in the extracts as well as a potent, ATP-dependent ribonucleolytic activity. The rates of both deadenylation and degradation were up-regulated by the presence of a variety of AU-rich elements in the body of substrate RNAs. Competition analyses demonstrated that trans-acting factors were required for RNA destabilization by AU-rich elements. The approximately 30-kD ELAV protein HuR specifically bound to RNAs containing an AU-rich element derived from the TNF-alpha mRNA in the in vitro system. Interaction of HuR with AU-rich elements, however, was not associated with RNA destabilization. Interestingly, recombinant ELAV proteins specifically stabilized deadenylated intermediates generated from the turnover of AU-rich element-containing substrate RNAs. These data suggest that mammalian ELAV proteins play a role in regulating mRNA stability by influencing the access of degradative enzymes to RNA substrates.

Duke Scholars

Published In

Genes Dev

DOI

ISSN

0890-9369

Publication Date

January 15, 1999

Volume

13

Issue

2

Start / End Page

188 / 201

Location

United States

Related Subject Headings

  • Tumor Necrosis Factor-alpha
  • Ribonucleoproteins
  • Response Elements
  • Recombinant Proteins
  • RNA-Binding Proteins
  • RNA, Messenger
  • RNA Processing, Post-Transcriptional
  • Precipitin Tests
  • Poly A
  • Mutation
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ford, L. P., Watson, J., Keene, J. D., & Wilusz, J. (1999). ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system. Genes Dev, 13(2), 188–201. https://doi.org/10.1101/gad.13.2.188
Ford, L. P., J. Watson, J. D. Keene, and J. Wilusz. “ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system.Genes Dev 13, no. 2 (January 15, 1999): 188–201. https://doi.org/10.1101/gad.13.2.188.
Ford LP, Watson J, Keene JD, Wilusz J. ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system. Genes Dev. 1999 Jan 15;13(2):188–201.
Ford, L. P., et al. “ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system.Genes Dev, vol. 13, no. 2, Jan. 1999, pp. 188–201. Pubmed, doi:10.1101/gad.13.2.188.
Ford LP, Watson J, Keene JD, Wilusz J. ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system. Genes Dev. 1999 Jan 15;13(2):188–201.

Published In

Genes Dev

DOI

ISSN

0890-9369

Publication Date

January 15, 1999

Volume

13

Issue

2

Start / End Page

188 / 201

Location

United States

Related Subject Headings

  • Tumor Necrosis Factor-alpha
  • Ribonucleoproteins
  • Response Elements
  • Recombinant Proteins
  • RNA-Binding Proteins
  • RNA, Messenger
  • RNA Processing, Post-Transcriptional
  • Precipitin Tests
  • Poly A
  • Mutation